Cargando…
Glucose and glycogen in the diabetic kidney: Heroes or villains?
Glucose metabolism in the kidney is currently foremost in the minds of nephrologists, diabetologists and researchers globally, as a result of the outstanding success of SGLT2 inhibitors in reducing renal and cardiovascular disease in individuals with diabetes. However, these exciting data have come...
| Autores principales: | , |
|---|---|
| Formato: | Online Artículo Texto |
| Lenguaje: | English |
| Publicado: |
Elsevier
2019
|
| Materias: | |
| Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6796499/ https://www.ncbi.nlm.nih.gov/pubmed/31405756 http://dx.doi.org/10.1016/j.ebiom.2019.07.067 |